医药板块正在走出至暗时刻。三生制药正在进入收获期。近期,港股上市公司三生制药(HK1530)发布了2024年财报,财报显示报告期内,公司实现营收91.08亿元,同比增长16.53%;实现归母净利润为20.90亿元,同比增长34.93%;经调整净利润为23.19亿港元,同比增长18.8%,每股盈利为0.86元。同财报一起发布的还有一份派息计划。三生制药表示,拟派发末期股息每股25港仙。三生制药称,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.